Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

Semaglutide injections effectively support weight loss by regulating appetite and glucose levels, offering benefits for ...

A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

Long-term weight loss for patients with obesity proved mostly successful after taking prescription-only injectable ...

Representational Photo The exploration of novel peptides for their potential impact on metabolic pathways has been a ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

MADRID — The benefits of semaglutide treatment in reducing kidney disease, cardiovascular, and mortality risks in people with ...

More Tennessee companies are covering weight-loss injections in health care benefit plans. This could impact the state's high ...

Some plans include clinical options like prescription drugs. Over the years, options like Semaglutide and Tirzepatide have ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

Among participants with no history of major psychopathology, there is no association between semaglutide and depression and suicidality.